For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Dextran Therapy Arm | antibiotic therapy in addition to dextran 70, 1.0 g/kg on days one, two and three Dextran 70 : dextran 70, 1.0 g/kg on days one, two and three | None | None | 0 | 4 | 4 | 4 | View |
| Standard of Care Albumin Arm | antibiotic therapy in addition to human albumin, 1.5 g/kg on day one and 1.0 g/kg on day three human albumin : human albumin 1.5 g/kg on day one and 1.0 g/kg on day three | None | None | 0 | 4 | 3 | 4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Muscle cramps | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Hepatic Encephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Clostridium difficle colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Excess ascites recurrence | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |